Professional Documents
Culture Documents
Taaleem - IPO Note - Mar21
Taaleem - IPO Note - Mar21
Taaleem - IPO Note - Mar21
Offering Syndicate
Coordinator & Bookrunner CI Capital Investment Banking
49.00%
51.00% Legal Advisor Matouk Bassiouny & Hennawy
Fin. Stat. Auditor PricewaterhouseCoopers
Indep. Financial Advisor BDO Khaled & Co.
Source: Company disclosure, Sigma Research
Sphinx Obelisk Free Float Others
Table of Contents
Valuation
In an attempt to reach a guideline for TALM’s fair value, we conducted 2 valuation scenarios; with the
main underlying difference being our assumptions regarding revenues (and by extension COGS and net
profit). We utilized the DCF valuation method in both scenarios, with a terminal growth rate of 7%, and an
adjusted beta of 0.75. However, different discount rates were assumed regarding terminal WACC in each
scenario. It is important to note that we excluded Badya University from our valuation as we believe any
value it will add to TALM will only be reflected in the very long term.
Higher-end Scenario
In the higher-end scenario we value TALM at EGP 6.59/share. This scenario assumes TALM’s Nahda
University (NUB)’s revenues will grow at a 5-year CAGR of 24%, and charge an average tuition fee of EGP
120k in the final year of our forecast horizon (2025), with a utilization rate of 75%. Our tuition fees
assumption is based on the average fees of different universities in Egypt for reference, while the 75%
utilization rate was based on NUB’s historical average utilization rate of 77%, which we believe will be
maintained going forward. We also assumed the Pupil To Teacher ratio (PTR) will be in line with NUB's
historical average of 11.75x. Higher capacities and the expected increase in averages tuition fees will lead to
a higher GPM from the current 65% to 71% by 2025.
This scenario’s Fair Value (FV) of EGP 6.59/share offers a limited upside potential of 14% from the IPO final
offering price of EGP 5.75/share, and implies a P/E of 25x in 2021, which will normalize to 10x by 2025.
6.59 5% 6% 7% 8% 9%
Others (1Q21) - 13% 6.50 7.18 8.08 9.33 11.16
Equity value 4,813 14% 6.01 6.55 7.23 8.14 9.40
15% 5.61 6.05 6.59 7.28 8.20
No. of Shares (mn) 730 16% 5.28 5.64 6.09 6.63 7.33
FV/share (EGP) 6.59 17% 5.01 5.31 5.68 6.12 6.68
Valuation (Cont.’d)
Lower-end Scenario
In the lower-end scenario we value TALM at EGP 5.58/share. This scenario assumes that the company will
be able to grow its revenues at a 5-year CAGR of 18%. In order to reach the terminal year’s average tuition
fees in this scenario, we applied a c13% discount to our bullish scenario’s target fees of EGP 120k (EGP
105k). We also assumed that NUB's utilization rate will reach 65% by 2025, and kept the PTR the same as
that in our bullish scenario. Said assumptions imply that the current GPM of 65% will be maintained over our
forecast horizon.
Our bearish scenario FV of EGP 5.58/share implies a downside of 3% from the IPO final offering price of EGP
5.75/share, and translates to a P/E of 21.6x in 2021, normalizing to 12.3x by 2025. That being said, we view
this scenario as overly pessimistic, and are more inclined to believe that the bullish scenario will materialize.
Summary of DCF valuation
In EGPmn, otherwise stated 2021f 2022f 2023f 2024f 2025f
5.58 5% 6% 7% 8% 9%
Others (1Q21) - 12% 5.51 6.17 7.10 8.45 10.64
13% 5.03 5.54 6.22 7.15 8.52
Equity value 4,076
14% 4.66 5.07 5.58 6.26 7.20
No. of Shares (mn) 730 15% 4.36 4.69 5.10 5.62 6.30
FV/share (EGP) 5.58 16% 4.12 4.39 4.72 5.13 5.66
• Higher growth in average tuition fees than expected • Unfavorable regulations that may negatively affect
• Higher than expected enrollment of new students student intake quota increases
• Faster roll-out of Badya University • Unfavorable changes in working capital dynamics
• Lower utilization rate than expected.
• Lower growth in average tuition fees than expected.
• Slower than expected additions of new capacities
TALM vs CIRA
Where TALM stands relative to CIRA
TALM CIRA
vs
2018 2019 2020 2018 2019 2020
Financial Performance
Revenues (EGPmn) 274 354 450 517 705 1,088
Revenue 2018-20 CAGR 28% 45%
Gross Profit (EGPmn) 164 218 294 269 376 557
GPM 60% 62% 65% 52% 53% 51%
EBITDA (EGPmn) 102 166 232 219 303 482
EBITDA Margin 37% 47% 51% 42% 43% 44%
Net Profit after MI (EGPmn) 62 110 142 120 188 255
NPM 23% 31% 32% 23% 27% 23%
NP 2018-20 CAGR 52% 46%
Selected Ratios & Multiples
RoE 45% 59% 21% 26% 27% 26%
RoA 5% 9% 10% 13% 15% 13%
Net Debt (Cash)/EBITDA -2.04x -1.66x -0.74x 0.09x -0.25x 0.78x
P/E * 68.02x 38.15x 29.49x 27.45x 34.65x 27.95x
EV/EBITDA nm nm 3.29x 2.38x 2.70x 3.07x
EV/Sales nm nm 1.69x 1.01x 1.16x 1.36x
Operations
Number of Schools na 19 19 20
K-12 Average Tuition Fees (EGP) na 10,812 11,442 16,600
K-12 Seats Capacity na 26,400 26,400 28,300
K-12 Utilization Rate na 81% 92% 94%
Number of Faculties 6 6 7 8 9 10
High-ed Average Tuition Fees (EGP) 49,921 61,504 76,906 43,042 43,670 47,969
High-ed Seats Capacity 6,500 6,500 6,935 11,280 13,030 13,310
High-ed Utilization Rate 79% 83% 80% 49% 61% 78%
Source: Companies’ disclosures, Sigma Research
*TALM’s PE is based on the IPO price of 5.75/share
Investment Thesis
I. Owns and manages the largest and first private university in Upper Egypt
TALM is the owner of Nahda University (NUB), which is the first and largest private university of the 2
currently operating in Upper Egypt. NUB benefited from the first-mover advantage, enabling the university
to build a strong reputation in Upper Egypt's populated region. NUB started operations in 2006, with 3
faculties, which it managed to increase to the currently operating 8 faculties, with a total capacity of c.11k
students. Given its size and reputation, we believe NUB is well placed to take advantage of any potential
growing demand for higher education in Upper Egypt. Furthermore, NUB is located in the Beni Suef
governorate, which is in close proximity to Greater Cairo, allowing the university to attract students from
both areas: Upper Egypt and Greater Cairo.
University Type Establishment Date No. of students (2018/19) PTR (2018/19) No. of faculties
II.Enjoys robust revenue growth with margins improvement and strong cash position
TALM was able to grow its revenue at a 2-year CAGR (2018-2020) of 28%, due to the continuous Y-o-Y
increase in average tuition fees, and a steady growth in the number of new students. The company’s Gross
Profit Margin (GPM) has been improving Y-o-Y, expanding from 60% in 2018 to 65% in 2020; supported by
TALM’s focus on high-margin faculties and efficient cost management. The company’s EBITDA margin has
notably expanded from 37% in 2018 to 51% in 2020, on the back of a significant drop in G&A as percentage
of revenues from 35% in 2018 to 23% in 2020. Furthermore, TALM collects tuition fees prior the beginning of
each academic semester, resulting in a strong cash position and a negative cash conversion cycle; granting
the company the luxury of an unlevered balance sheet.
Source: Company disclosure, Sigma Research Source: Company disclosure, Sigma Research
(280)
300.00 (282)
(286)
250.00 (284)
(286) (292)
200.00 (288)
(290) (299)
150.00
275.12 (292)
100.00 207.79 (294)
172.41 (296)
50.00 (298)
(300)
-
FY 2017/18 FY 2018/19 FY 2019/20
FY 2017/18 FY 2018/19 FY 2019/20
Cash conversion cycle (days)
Net Cash/(Debt) (EGPmn)
Source: Company disclosure, Sigma Research Source: Company disclosure, Sigma Research
TALM’s main focus and expansion plans are primarily directed towards high margin faculties, such as those
pertaining to health sciences (medicine, dentistry, and pharmacy), to continue improving its margins. NUB's
margins for the dentistry, pharmacy and medicine faculties stand at 88%, 87% and 86%, respectively,
compared to an average margin of 68% for all other faculties. Said high-margin faculties accounted for 67%
of NUB's total student enrollment for the 2020/2021 academic year. Furthermore, NUB entered an exclusive
partnership with the Medical University of Vienna International (MUVI) to develop and launch the former’s
medicine faculty, as well as improve its dentistry faculty. As a result of this partnership, NUB was able to
jointly develop with MUVI a curricula for NUB's medicine and dentistry faculties, build the largest private
medicine university in Egypt, and further enhance its reputation and offerings.
.
The process of establishing a new private university in Egypt is a long and rigorous one. To operate as an
educational institution in the country, universities must obtain a presidential decree, which requires an
approval from from the Ministry of Higher Education (MoHE) and the Prime Minister's cabinet. Furthermore,
it takes time to build a strong brand and reputation, which is sought by both students and teachers alike, not
to mention the considerable initial investment needed to build a university; such as the cost of acquiring a
land as well as construction and development costs. As a result, we believe TALM is shielded from the flood
of new entrants into the private education space.
Company Profile
of the leading higher education providers in Egypt. It owns Name Designation Status
and operates Nahda University “NUB”, the first and largest Hesham Gohar Chairman Non-excutive
Ahmed Badreldin Vice Chairman Non-excutive
university in Upper Egypt, which came under its management
Mohamed El Rashidi Managing Director Excutive
in 2016. NUB has a total capacity of more than 11k students Mahmoud Attallah Board Member Non-excutive
as of the 2020/21 educational year, with 8 faculties including: Hazem Badran Board Member Non-excutive
pharmacy, dentistry, medicine, physiotherapy, engineering, Tarek Tantawy Board Member Non-excutive
Nabil Kamhawi Board Member Non-excutive
computer science, marketing & business administration, and Omar El Imam Board Member Non-excutive
media. In February 2021, the company formed a joint venture Samia EL Barrody Board Member Non-excutive
with Palm Hills Development Company (PHDC.CA), one of Youssef Haidar Board Member Non-excutive
Eskandar Tooma Board Member Non-excutive
Egypt’s leading real estate developers, to build Badya
University on a new campus in Palm Hill's Badya project, Source: Company disclosure
which spans a land area of 133k sqm.
Taaleem’s timeline
Balance Sheet (in EGPmn) 2018a 2019a 2020f 2021f 2022f 2023f
Cash & cash equivalents 275.12 329.08 537.56 760.85 1,079.91 1,453.71
Accounts receivables 35.84 25.24 54.24 68.76 85.70 105.24
Inventory 6.49 5.06 9.16 10.96 13.16 15.64
Fixed assets (net) 503.45 651.33 708.43 791.00 857.00 947.98
Intangible assets 522.61 522.33 522.33 522.33 522.33 522.33
Other non-current assets 17.69 17.12 17.12 17.12 17.12 17.12
Total assets 1,361.19 1,550.15 1,848.84 2,171.01 2,575.22 3,062.01
Accounts payables 47.92 74.18 81.37 97.27 116.88 138.90
Deferred revenue 210.95 179.00 296.36 375.67 468.24 574.97
Provisions 738.80 5.62 5.62 5.62 5.62 5.62
CPLTD - - - - - -
Other current liabilities 28.96 46.05 46.05 46.05 46.05 46.05
LTD - - - - - -
Other non-current liabilities 99.95 154.28 154.28 154.28 154.28 154.28
Total liabilities 1,126.58 459.14 583.69 678.90 791.07 919.82
Shareholders equity 227.05 1,082.15 1,254.95 1,480.15 1,769.95 2,125.23
Minority interests 7.56 8.87 10.21 11.96 14.20 16.96
Total liabilities & equity 1,361.19 1,550.15 1,848.84 2,171.01 2,575.22 3,062.01
Cash Flow Statement (in EGPmn) 2018a 2019a 2020f 2021f 2022f 2023f
Cash flow from operations 170.37 245.19 341.32 392.38 485.92 578.64
Cash flow from investing (90.78) (173.32) (113.65) (144.06) (134.67) (165.37)
Cash flow from financing (12.26) (17.90) (19.20) (25.02) (32.20) (39.48)
Net change in cash 67.33 53.96 208.48 223.29 319.06 373.80
Profitability & Growth Ratios 2018a 2019a 2020f 2021f 2022f 2023f
Balance Sheet (in EGPmn) 2018a 2019a 2020f 2021f 2022f 2023f
Cash & cash equivalents 275.12 329.08 533.09 716.59 942.12 1,197.54
Treasury bills
Accounts receivables 35.84 25.24 53.69 63.26 71.17 82.36
Inventory 6.49 5.06 9.16 10.70 12.45 14.50
Fixed assets (net) 503.45 651.33 707.27 778.40 822.66 880.67
Intangible assets 522.61 522.33 522.33 522.33 522.33 522.33
Other non-current assets 17.69 17.12 17.12 17.12 17.12 17.12
Total assets 1,361.19 1,550.15 1,842.66 2,108.39 2,387.84 2,714.52
Accounts payables 47.92 74.18 81.37 95.00 110.53 128.73
Deferred revenue 210.95 179.00 293.33 345.60 388.82 449.99
Provisions 738.80 5.62 5.62 5.62 5.62 5.62
CPLTD - - - - - -
Other current liabilities 28.96 46.05 46.05 46.05 46.05 46.05
LTD - - - - - -
Other non-current liabilities 99.95 154.28 154.28 154.28 154.28 154.28
Total liabilities 1,126.58 459.14 580.65 646.56 705.30 784.67
Shareholders equity 227.05 1,082.15 1,251.82 1,450.12 1,669.12 1,914.52
Minority interests 7.56 8.87 10.18 11.72 13.42 15.33
Total liabilities & equity 1,361.19 1,550.15 1,842.66 2,108.39 2,387.84 2,714.52
Cash Flow Statement (in EGPmn) 2018a 2019a 2020f 2021f 2022f 2023f
Cash flow from operations 170.37 245.19 335.35 338.06 361.69 412.11
Cash flow from investing (90.78) (173.32) (112.48) (132.53) (111.83) (129.42)
Cash flow from financing (12.26) (17.90) (18.85) (22.03) (24.33) (27.27)
Net change in cash 67.33 53.96 204.01 183.50 225.53 255.43
Profitability & Growth Ratios 2018a 2019a 2020f 2021f 2022f 2023f
Business Development
Karim Riad
Head of Business Development
Karim.Riad@sigma-capital.com
Tel: +(202) 3335 5353
Neither Sigma, nor any of its affiliates, directors, officers, investors or shareholders guarantee the completeness or accuracy of the Information. Although
due care has been taken in compiling this Report, it cannot be excluded that it is incomplete or contain errors. Possible errors or incompleteness of the
Information do not constitute grounds for liability, either with regard to direct, indirect or consequential damages. In particular, Sigma, its affiliates,
directors, officers, investors and shareholders are not liable for the accuracy and completeness of statements, plans or other details contained in the
Information concerning any mentioned entity, their affiliates, strategies, economic situations, market and competitive situations, regulatory environment,
etc. derived from the Information contained in this Report. In any event, and notwithstanding the foregoing, the liability of Sigma shall be restricted to
gross negligence and willful misconduct in essential tasks. In any case, the liability of Sigma is limited to typical, expectable damages and the liability for
any indirect damages is excluded.
Sigma, its affiliates, directors, officers, investors, employees or shareholders may have a long, short or other position in a security of an entity mentioned
herein. The reader of this Report who is interested in purchasing any type of security is urged to read the offering documents and other relevant public
documents in full, and to conduct their own research and due diligence and verify all claims before investing in any security. Sigma encourages all parties
to invest carefully and read the investor information available on the web sites of any entity mentioned in this Report in addition to that information
available through the relevant governing authority, if any. Investing in securities is speculative and carries a high degree of risk. The reader of this Report
is encouraged to consult with their financial advisors, brokers, accountants, or attorneys (in addition to conducting their own due diligence) prior to
making an investment decision in any security.
Sigma or its affiliates may from time to time perform consulting or other services for or solicit or perform consulting or other investment banking services
from any entity mentioned in this Report. The reader of this Report should seek financial advice regarding the appropriateness of investing in any security
or investment strategies mentioned in this Report and should understand that statements regarding future prospects may not be realized inasmuch as
that income from such security, if any, may fluctuate and that each security’s price or value may rise or fall substantially. Accordingly, an investor may
receive back less than originally invested.
Unknown risk, including bankruptcy, uncertainties, as well as other uncontrollable or unknown factors may cause actual results to materially differ from
the results, performance or expectations expressed or implied by such forward-looking statements. Sigma cautions the reader of this Report that such
forward-looking statements in this Report are not guarantees of future performance. Past performance is not indicative of future performance. The
results, performance or achievements of an entity mentioned in this Report could differ materially from the results expressed in, or implied by these
forward looking statements. Sigma does not assume any responsibility or liability for any decision made as a result of reading this Report. Readers hereby
acknowledge that any reliance upon any materials shall be at the reader’s sole risk.
Sigma reserves the right, in its sole discretion and without any obligation to provide notice to the Reader, to make improvements to, or correct any error
or omission(s) in any portion of this Report, or materials related thereto. Sigma expressly disclaims any and all warranties, express or implied, including
without limitation warranties or merchantability and fitness for a particular purpose, with respect to this Report. In no event shall Sigma be liable for any
direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to this Report. This Report shall not be copied nor
reproduced in any form without the expressed written and authorized consent of Sigma. Copyright 2016: Sigma. All rights reserved.
Sigma Securities S.A.E, Level 1, Al-Foad Administrative Building, 37 Gameat El Dowal El Arabeya Street, Mohandessin, Giza 12411– Egypt
Tel: +202 3335 7575 - Fax: +202 3335 0066
For U.S. persons only: This research report is a product of SIGMA SECURITIES BROKERAGE, which is the employer of the research analyst(s) who has
prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated
persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required
to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things,
communications with a subject company, public appearances and trading securities held by a research analyst account.
This report is intended for distribution by SIGMA SECURITIES BROKERAGE, only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the
U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on
Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return
the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major
Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct
certain business with Major Institutional Investors, SIGMA SECURITIES BROKERAGE, has entered into an agreement with a U.S. registered broker-dealer,
Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another
U.S. registered broker dealer.